ClinicalTrialsFinder
RecruitingNot ApplicableNCT06736457

Study on Safety and Performance of AdvanCore Bone Void Filler

Sponsor

Artur Salgado SA

Enrollment

190 participants

Start Date

May 29, 2025

Study Type

INTERVENTIONAL

Conditions

Bone fracturesBone LossBone GraftBone Defects

Summary

The objective of this study is to evaluate the safety and performance of AdvanCore implantable bone graft through a 12-month follow-up period in a prospective, parallel-group design, non-controlled, open label, multi-center and real-world setting study. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called AdvanCore bone grafting for people with bone defects, bone graft, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAdvanCore bone grafting

AdvanCore medical device is implanted making sure that is in direct contact with all surfaces of the defect area.

Locations(4)

Unidade Local de Saúde do Alto Ave

Guimarães, Braga District, Portugal

Unidade Local de Saúde de São João

Porto, Porto District, Portugal

Unidade Local de Saúde do Médio Tejo

Tomar, Santarém District, Portugal

Unidade Local de Saúde de Trás-os-Montes e Alto Douro

Lordelo, Vila Real District, Portugal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06736457

Related Trials

Naringenin Supplementation in Bone Fracture Patients

NCT066127621 location

Evaluation of the Safety and Performance of the Neocement® Inject P

NCT069732391 location

Evaluation of the Safety and Performance of the Neocement®

NCT069732261 location

Bone, Exercise, Alendronate, and Caloric Restriction

NCT057647332 locations

The Use of Two Bone Substitutes in Adjunct to EMD for the Treatment of One- and Two-wall Intrabony Defects.

NCT075462791 location